Introduced
by
To provide sentencing guidelines for the increased penalties proposed by House Bills 5174 and 5175 for adulterating, misbranding or substituting a drug or medical device for the purpose of defrauding or harming another person.
Referred to the Committee on Criminal Justice
Reported without amendment
With the recommendation that the substitute (H-1) be adopted and that the bill then pass.
Substitute offered
To replace the previous version of the bill with one containing technical changes that do not affect its substance as previously described.
The substitute passed by voice vote
Passed in the House 104 to 0 (details)
Referred to the Committee on Judiciary
Reported without amendment
With the recommendation that the substitute (S-2) be adopted and that the bill then pass.
Substitute offered
To replace the previous version of the bill with one that revises details but does not change the substance of the bill as previously described.
The substitute passed by voice vote
Passed in the Senate 36 to 0 (details)
To provide sentencing guidelines for the increased penalties proposed by House Bills 5174 and 5175 for adulterating, misbranding or substituting a drug or medical device for the purpose of defrauding or harming another person.
To concur with the Senate-passed version of the bill.
Passed in the House 103 to 0 (details)
